You just read:

Eiger Announces Results Demonstrating Benefit of Ubenimex and Leukotriene B4 (LTB4) Modulation in Experimental Lymphedema

News provided by

Eiger BioPharmaceuticals, Inc.

May 17, 2017, 08:00 ET